Issues surrounding clinical trial endpoints in solid malignancies with a focus on metastatic non-small cell lung cancerGARON, Edward B.Lung cancer. 2012, Vol 77, Num 3, pp 475-481, issn 0169-5002, 7 p.Article

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trialGARON, Edward B; CIULEANU, Tudor-Eliade; CZYZEWICZ, Grzegorz et al.Lancet (British edition). 2014, Vol 384, Num 9944, pp 665-673, issn 0140-6736, 9 p.Article

In vitro and in vivo evaluation and a case report of intense nanosecond pulsed electric field as a local therapy for human malignanciesGARON, Edward B; SAWCER, David; VEMIER, P. Thomas et al.International journal of cancer. 2007, Vol 121, Num 3, pp 675-682, issn 0020-7136, 8 p.Article

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non―Small-Cell Lung CancerPATEL, Jyoti D; SOCINSKI, Mark A; GUBA, Susan C et al.Journal of clinical oncology. 2013, Vol 31, Num 34, pp 4349-4357, issn 0732-183X, 9 p.Article

Characteristics of Lung Cancers Harboring NRAS MutationsOHASHI, Kadoaki; SEQUIST, Lecia V; YUMEI PAN et al.Clinical cancer research (Print). 2013, Vol 19, Num 9, pp 2584-2591, issn 1078-0432, 8 p.Article

Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung CancerRUDIN, Charles M; HANN, Christine L; RANSON, Malcolm R et al.Clinical cancer research (Print). 2012, Vol 18, Num 11, pp 3163-3169, issn 1078-0432, 7 p.Article

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted DrugsKRIS, Mark G; JOHNSON, Bruce E; YU SHYR et al.JAMA, the journal of the American Medical Association. 2014, Vol 311, Num 19, pp 1998-2006, issn 0098-7484, 9 p.Article

Phase I Dose-Escalation Study of the Pan-HER Inhibitor, PF299804, in Patients with Advanced Malignant Solid TumorsJÄNNE, Pasi A; BOSS, David S; MILLHAM, Robert et al.Clinical cancer research (Print). 2011, Vol 17, Num 5, pp 1131-1139, issn 1078-0432, 9 p.Article